These findings are in general accordance with what has been described in most of the previous studies when looking at overall populations and EGFR staining as a prognostic marker in ovarian cancer, while some studies using smaller patient cohorts or restricted patient subsets have reported statistically significant associations (Table 6). This evidence concerns the gene EGFR and ovarian carcinoma.